List of insiders holdings for Kiniksa Pharmaceuticals International plc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
2025-06-05 17:06:51 | 29,680 2,839,604 |
2,869,284 | Form 4 |
| 2 | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Chen Bihua 10% Owner |
2019-02-14 16:14:48 | 831,000 0 |
831,000 | Form 13G |
| 3 | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner |
2019-02-14 16:14:48 | 831,000 0 |
831,000 | Form 13G |
| 4 | BOESS CARSTEN 10% Owner |
2018-05-29 19:19:09 | 559,016 0 |
559,016 | Form 4 |
| 5 | Patel Sanj K CHAIRMAN & CEO |
2025-05-28 17:25:05 | 240,223 109,795 |
350,018 | Form 4 |
| 6 | Tessari Eben CHIEF OPERATING OFFICER |
2025-06-11 17:32:32 | 294,737 0 |
294,737 | Form 4 |
| 7 | Paolini John F. CHIEF MEDICAL OFFICER |
2025-05-09 17:01:05 | 123,270 0 |
123,270 | Form 4 |
| 8 | Malley Thomas Director |
2025-06-05 17:02:16 | 32,143 71,967 |
104,110 | Form 4 |
| 9 | Mahoney Stephen F. President & COO |
2019-09-19 16:18:37 | 82,000 0 |
82,000 | Form 4 |
| 10 | Heberlig Chris EVP & CFO |
2019-09-19 16:16:52 | 50,000 0 |
50,000 | Form 4 |
| 11 | Quart Barry D Director |
2025-06-11 17:35:55 | 45,430 0 |
45,430 | Form 4 |
| 12 | Levy Richard S Director |
2025-06-05 17:05:51 | 36,970 0 |
36,970 | Form 4 |
| 13 | Megna Michael R CHIEF ACCOUNTING OFFICER |
2025-06-05 16:50:16 | 33,337 0 |
33,337 | Form 4 |
| 14 | Popovits Kimberly J Director |
2025-06-05 16:55:57 | 32,143 0 |
32,143 | Form 4 |
| 15 | McCain Tracey L Director |
2025-06-05 16:59:33 | 32,143 0 |
32,143 | Form 4 |
| 16 | Cole G Bradley Director |
2025-06-05 17:07:41 | 32,143 0 |
32,143 | Form 4 |
| 17 | Pano Arian Chief Clinical Dev. Officer |
2021-09-07 17:19:21 | 27,213 0 |
27,213 | Form 4 |
| 18 | Ragosa Mark CHIEF FINANCIAL OFFICER |
2025-06-05 16:38:56 | 27,009 0 |
27,009 | Form 4 |
| 19 | Beetham Thomas W. EVP & Chief Legal Officer |
2021-03-23 17:32:56 | 10,142 0 |
10,142 | Form 4 |
| 20 | Moat Ross CHIEF COMMERCIAL OFFICER |
2025-06-05 16:46:35 | 9,415 0 |
9,415 | Form 4 |
| 21 | Rizvi Qasim Chief Commercial Officer |
2021-01-05 17:07:03 | 5,176 0 |
5,176 | Form 4 |
| 22 | Boyd Meta Cantey Director |
2024-10-08 17:08:24 | 0 0 |
0 | Form 3 |
| 23 | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. *Possible member of 10% group 10% Owner |
2020-02-13 12:42:47 | 0 0 |
0 | Form 13G |
| 24 | Biggar Stephen R Director |
2018-05-23 20:23:42 | 0 0 |
0 | Form 3 |